Literature DB >> 23996276

A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.

Richard A Armstrong1, Paul T Kotzbauer, Joel S Perlmutter, Meghan C Campbell, Kyle M Hurth, Robert E Schmidt, Nigel J Cairns.   

Abstract

The α-synuclein-immunoreactive pathology of dementia associated with Parkinson disease (DPD) comprises Lewy bodies (LB), Lewy neurites (LN), and Lewy grains (LG). The densities of LB, LN, LG together with vacuoles, neurons, abnormally enlarged neurons (EN), and glial cell nuclei were measured in fifteen cases of DPD. Densities of LN and LG were up to 19 and 70 times those of LB, respectively, depending on region. Densities were significantly greater in amygdala, entorhinal cortex (EC), and sectors CA2/CA3 of the hippocampus, whereas middle frontal gyrus, sector CA1, and dentate gyrus were least affected. Low densities of vacuoles and EN were recorded in most regions. There were differences in the numerical density of neurons between regions, but no statistical difference between patients and controls. In the cortex, the density of LB and vacuoles was similar in upper and lower laminae, while the densities of LN and LG were greater in upper cortex. The densities of LB, LN, and LG were positively correlated. Principal components analysis suggested that DPD cases were heterogeneous with pathology primarily affecting either hippocampus or cortex. The data suggest in DPD: (1) ratio of LN and LG to LB varies between regions, (2) low densities of vacuoles and EN are present in most brain regions, (3) degeneration occurs across cortical laminae, upper laminae being particularly affected, (4) LB, LN and LG may represent degeneration of the same neurons, and (5) disease heterogeneity may result from variation in anatomical pathway affected by cell-to-cell transfer of α-synuclein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996276      PMCID: PMC4041534          DOI: 10.1007/s00702-013-1084-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  38 in total

1.  Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria.

Authors:  H Braak; E Braak
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  Argyrophilic grains: a distinct disease or an additive pathology?

Authors:  Keith A Josephs; Jennifer L Whitwell; Joseph E Parisi; David S Knopman; Bradley F Boeve; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Dennis W Dickson
Journal:  Neurobiol Aging       Date:  2006-12-26       Impact factor: 4.673

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  [Argyrophilic grain disease: differentiation from Alzheimer disease].

Authors:  M Tolnay; A U Monsch; H B Staehelin; A Probst
Journal:  Pathologe       Date:  1999-05       Impact factor: 1.011

6.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

7.  Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.

Authors:  Richard A Armstrong; William Ellis; Ronald L Hamilton; Ian R A Mackenzie; John Hedreen; Marla Gearing; Thomas Montine; Jean-Paul Vonsattel; Elizabeth Head; Andrew P Lieberman; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2009-12-10       Impact factor: 3.575

Review 8.  Visual signs and symptoms of Parkinson's disease.

Authors:  Richard A Armstrong
Journal:  Clin Exp Optom       Date:  2008-03       Impact factor: 2.742

9.  alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.

Authors:  Minna Oinas; Anders Paetau; Liisa Myllykangas; Irma-Leena Notkola; Hannu Kalimo; Tuomo Polvikoski
Journal:  Acta Neuropathol       Date:  2010-06       Impact factor: 17.088

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  25 in total

1.  Laminar degeneration of frontal and temporal cortex in Parkinson disease dementia.

Authors:  Richard A Armstrong
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

2.  Calcineurin determines toxic versus beneficial responses to α-synuclein.

Authors:  Gabriela Caraveo; Pavan K Auluck; Luke Whitesell; Chee Yeun Chung; Valeriya Baru; Eugene V Mosharov; Xiaohui Yan; Manu Ben-Johny; Martin Soste; Paola Picotti; Hanna Kim; Kim A Caldwell; Guy A Caldwell; David Sulzer; David T Yue; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-13       Impact factor: 11.205

Review 3.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

4.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

5.  Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.

Authors:  Esteban Luna; Samantha C Decker; Dawn M Riddle; Anna Caputo; Bin Zhang; Tracy Cole; Carrie Caswell; Sharon X Xie; Virginia M Y Lee; Kelvin C Luk
Journal:  Acta Neuropathol       Date:  2018-03-03       Impact factor: 17.088

6.  Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.

Authors:  Na Wang; Liang Zhang; HuaGuang Yang; XiaoGuang Luo; GuoGuang Fan
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

7.  Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.

Authors:  David H Adamowicz; Subhojit Roy; David P Salmon; Douglas R Galasko; Lawrence A Hansen; Eliezer Masliah; Fred H Gage
Journal:  J Neurosci       Date:  2016-12-30       Impact factor: 6.167

8.  A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy.

Authors:  R A Armstrong; A C McKee; T D Stein; V E Alvarez; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2016-04-15       Impact factor: 8.090

9.  Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.

Authors:  Chandana Buddhala; Meghan C Campbell; Joel S Perlmutter; Paul T Kotzbauer
Journal:  Neurobiol Aging       Date:  2014-08-04       Impact factor: 4.673

10.  Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.

Authors:  Negin Nouraei; Daniel M Mason; Kristin M Miner; Michael A Carcella; Tarun N Bhatia; Benjamin K Dumm; Dishaben Soni; David A Johnson; Kelvin C Luk; Rehana K Leak
Journal:  Exp Neurol       Date:  2017-10-19       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.